Roughly 2 billion people worldwide are estimated to have some form of allergic condition, making allergies one of the most common chronic health issues on the planet. That number spans hay fever, asthma, eczema, food allergies, and drug allergies, and it has been climbing steadily for decades. No single global registry tracks every allergy diagnosis, but piecing together prevalence data for each major allergic disease gives a clear picture of just how widespread these conditions are.
Hay Fever Affects Over 400 Million People
Allergic rhinitis, commonly called hay fever, is the most prevalent allergic disease in the world. It affects more than 400 million people globally, with prevalence rates between 10% and 30% among adults and over 40% among children. In the United States alone, about 7.8% of adults and 9% of children report hay fever symptoms in a given year, though true rates are likely higher since many people never get a formal diagnosis.
These numbers represent a dramatic increase over the past century. In North America during the 1930s and 1940s, only about 3% of the population had hay fever. By 1970, that had risen to 10%. By 2000, it reached 30% of adults and 40% of children. Today, more than half of all Americans test positive to at least one of the top 10 allergens.
Asthma and Eczema Add Hundreds of Millions More
Asthma affected an estimated 363 million people in 2023, according to the World Health Organization, and caused 442,000 deaths that year. A large share of asthma cases are triggered or worsened by allergens like dust mites, mold, pet dander, and pollen, making asthma one of the most serious consequences of allergic disease.
Eczema (atopic dermatitis) adds another 223 million people to the global allergy burden. About 43 million of those are children between the ages of 1 and 4, which reflects how early allergic conditions tend to appear. Eczema is often the first step in what allergists call the “allergic march,” where children who develop eczema in infancy go on to develop food allergies, hay fever, or asthma later in childhood.
Food Allergies Are Rising Fast
Food allergy affects approximately 8% of children and 10% of adults in developed countries. A meta-analysis of 51 studies found prevalence rates ranging anywhere from 3% to 35% depending on how allergy was defined and measured. When only studies using objective testing (like skin prick tests or oral food challenges) were included, the average dropped to about 3%, suggesting that self-reported food allergy is significantly more common than confirmed food allergy.
The variation between countries is striking. A survey across 10 European countries found that Finland had the highest reported prevalence of food allergy in children at 11.7%, while Austria was the lowest at 1.7%. Australia has some of the highest rates in the world, particularly in Melbourne. In the United States, the number of children allergic to peanuts doubled between 1997 and 2002, a trend that drew widespread attention and reshaped school lunch policies across the country.
One in Three Children Has an Allergic Condition
Children bear a disproportionate share of the allergy burden. In developed countries, one in three children has at least one allergic disorder, whether that’s food allergy, eczema, hay fever, or asthma. Allergic diseases are now among the most common reasons for pediatric doctor visits and emergency room trips in high-income nations.
Childhood prevalence rates also vary by demographics. In the U.S., white children are slightly more likely to have hay fever (10%) compared to Black children (7%), though asthma rates show the opposite pattern, with Black children experiencing higher rates and more severe outcomes.
Why Allergies Keep Increasing
The rise in allergies over the past 50 years has been too rapid to be explained by genetics alone. Several environmental and lifestyle factors are driving the trend. The hygiene hypothesis suggests that children in industrialized nations are exposed to fewer infections and microbes early in life, which may leave their immune systems more likely to overreact to harmless substances like pollen or food proteins. Increased antibiotic use, smaller family sizes, less time outdoors, and more time in sealed, climate-controlled buildings all fit this pattern.
Climate change is also playing a role, particularly for hay fever. Warmer temperatures and higher carbon dioxide levels are extending pollen seasons and increasing the amount of pollen that plants produce. Urbanization concentrates air pollution, which can damage the lining of the airways and make people more susceptible to airborne allergens. Dietary shifts toward more processed foods and fewer fermented or fiber-rich foods may also be reshaping the gut bacteria that help regulate immune responses.
The Financial Weight of Allergies
Allergies carry an enormous economic cost that goes well beyond pharmacy bills. In Australia, where about 30% of the population (8.2 million people) lives with allergic disease, the total financial cost was estimated at $18.9 billion in 2024, averaging $2,318 per person. Employers bear the largest share of that burden at 52%, mostly through lost productivity and sick days, followed by the federal government at 25%.
When non-financial costs are factored in, including reduced quality of life, sleep disruption, and limitations on daily activities, the total impact in Australia alone reaches an estimated $44.6 billion annually. These figures from a single country hint at the scale of the global economic burden, which runs into hundreds of billions of dollars each year across healthcare systems, workplaces, and households.
Severe Allergic Reactions Are Becoming More Common
Anaphylaxis, the most dangerous form of allergic reaction, was once considered rare but is now recognized as more common than previously thought. The lifetime prevalence is estimated at 0.3% to 5.1% of the population, and the global incidence sits at roughly 46 cases per 100,000 people per year. That rate is increasing by about 7.4% annually, a trend seen across multiple countries and age groups. In children, reported incidence ranges widely, from 1 to 761 per 100,000 depending on the region and how cases are tracked.
Despite the rising incidence, mortality from anaphylaxis remains low at fewer than 1 death per million people per year. The bigger concern is quality of life: people at risk of anaphylaxis often experience significant anxiety around food, travel, and social situations, and they typically need to carry emergency medication at all times.